Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Jounce Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 102 | 1 | 102 | +1 |
| Shares | 42.7M | 13.1K | 42.5M | −122.7K (−0.3%) |
| Value | $129.3M | $40.0K | $99.5M | −$29.7M (−23.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Jounce Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,400,000 | $3.28M | 0.57% |
| Healthcare of Ontario Pension Plan Trust Fund | 305,200 | $714.0K | 0.00% |
| Monarch Partners Asset Management LLC | 228,370 | $534.0K | 0.16% |
| Bridgeway Capital Management, LLC | 164,000 | $384.0K | 0.01% |
| Jefferies Group LLC | 132,115 | $309.1K | 0.01% |
| Gsa Capital Partners LLP | 97,317 | $228.0K | 0.03% |
| Caxton Associates LP | 37,345 | $87.0K | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 27,327 | $64.0K | 0.00% |
| CIBC Private Wealth Group, LLC | 20,425 | $48.0K | 0.00% |
| Balyasny Asset Management LLC | 11,177 | $26.0K | 0.00% |
| Simplex Trading, LLC | 10,968 | $25.0K | 0.00% |
| Group One Trading, L.P. | 2,334 | $5.00K | 0.00% |
| Federated Hermes, Inc. | 310 | $1.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 484 | $1.00K | 0.00% |
Sold out (13)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sofinnova Investments, Inc. | 981,928 | $2.98M |
| Ally Bridge Group (NY) LLC | 550,000 | $1.67M |
| Millennium Management LLC | 82,739 | $251.0K |
| D. E. Shaw & Co., Inc. | 52,462 | $159.0K |
| Marshall Wace, LLP | 39,339 | $119.0K |
| XTX Topco Ltd | 37,362 | $113.0K |
| Jump Financial, LLC | 36,500 | $111.0K |
| AQR Capital Management LLC | 34,981 | $106.0K |
| HRT Financial LP | 20,010 | $60.0K |
| Dynamic Technology Lab Private Ltd | 18,376 | $56.0K |
| Atom Investors LP | 11,388 | $35.0K |
| Spire Wealth Management | 2,000 | $6.00K |
| Nisa Investment Advisors, LLC | 660 | $2.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Frontier Wealth Management LLC | 13,099 | $40.0K |